Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - Veterinary Anaesthesia …, 2013 - Elsevier
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …
被引用次数：96 相关文章
[PDF] academia.edu

[PDF][PDF] Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - Veterinary …, 2012 - academia.edu
Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and
subcutaneous buprenorphine in conscious cats Page 1 RESEARCH PAPER Pharmacokinetic …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano, C Auberger… - 2013 - repositorio.unesp.br
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …
[PDF] psu.edu

[PDF][PDF] Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PV Steagall, L Pelligand, JW Sear, P Taylor - Veterinary Anaesthesia and …, 2012 - Citeseer
Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and
subcutaneous buprenorphine in conscious cats Page 1 See discussions, stats, and author …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - VETERINARY …, 2013 - bv.fapesp.br
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.

PVM Steagall, L Pelligand, T Giordano, C Auberger… - 2013 - cabidigitallibrary.org
Objective: To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.

PV Steagall, L Pelligand, T Giordano… - Veterinary …, 2012 - europepmc.org
Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and
subcutaneous buprenorphine in conscious cats. - Abstract - Europe PMC Sign in | Create an …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - Veterinary Anaesthesia …, 2012 - infona.pl
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - Veterinary …, 2013 - vaajournal.org
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …

Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats

PVM Steagall, L Pelligand, T Giordano… - Veterinary …, 2013 - scholars.cityu.edu.hk
Objective To describe simultaneous pharmacokinetics (PK) and thermal antinociception
after intravenous (IV), intramuscular (IM) and subcutaneous (SC) buprenorphine in cats …